Skip to main content

. 1966 Jul;25(4):353–355. doi: 10.1136/ard.25.4.353

Treatment of gout by reduction of uric acid production.

PMCID: PMC2453350 PMID: 5947580

353

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CHU E. W., MALMGREN R. A. EFFECT OF OROTIC ACID ON THE METASTASIS OF MAMMARY TUMORS IN MICE. Cancer Res. 1964 May;24:671–673. [PubMed] [Google Scholar]
HALL A. P., HOLLOWAY V. P., SCOTT J. T. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS. Ann Rheum Dis. 1964 Nov;23:439–446. doi: 10.1136/ard.23.6.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
Houpt J. B. The effect of allopurinol (HPP) in the treatment of gout. Arthritis Rheum. 1965 Oct;8(5):899–904. doi: 10.1002/art.1780080455. [DOI] [PubMed] [Google Scholar]
KERSLEY G. D., GIBBS A. R. Uricosuric agents in the treatment of gout. Ann Rheum Dis. 1960 Dec;19:351–355. doi: 10.1136/ard.19.4.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
Smyth C. J. Studies with allopurinol (HPP) in patients with tophaceous gout. Arthritis Rheum. 1965 Oct;8(5):907–910. doi: 10.1002/art.1780080457. [DOI] [PubMed] [Google Scholar]
Wyngaarden J. B. Xanthine oxidase inhibitors in the management of gout. Arthritis Rheum. 1965 Oct;8(5):883–890. doi: 10.1002/art.1780080452. [DOI] [PubMed] [Google Scholar]
YUE T. F., GUTMAN A. B. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. Am J Med. 1964 Dec;37:885–898. doi: 10.1016/0002-9343(64)90131-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES